Real-time enrollment status for this indolent lymphomas clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 6:12 PM UTC
| NCT Number | NCT06860880 |
| Recruiting Status | Recruiting |
| Condition | Indolent Lymphomas |
| Phase | NA |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Last Updated on CT.gov | July 1, 2026 (2 weeks ago) |
As of July 20, 2026: Clinical trial NCT06860880 is currently recruiting participants. This na study for indolent lymphomas is actively seeking new participants at 1 location across the United States. The study is sponsored by UNC Lineberger Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06860880 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06860880 was last updated 2 weeks ago (July 1, 2026). HelloStudys verifies this status automatically.